-
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
-
The Affordable Care Act’s Impact on Access to Cancer CareA study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
-
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
From the Editor-in-Chief
Innovative Therapy Takes a BiTE Out of CancerBispecific T-cell engagers (BiTEs) bring immune cells close enough to cancer cells to destroy them.
by William G. Nelson, MD, PhD
-
Forward Look
The Cost of Dental Side EffectsHead and neck cancer survivors often face significant costs for treatments not covered by health insurance.
by Kris Conner
-
Forward Look
Shining a Spotlight on Health-related Social NeedsHealth care teams should ask about support needs including transportation, housing, food and financial security.
by Darcy Lewis
-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
-
Forward Look
Immunotherapy Improves Survival in Early-stage Kidney CancerPeople who have surgery to remove kidney cancer that has a high chance of recurrence must weigh benefits and risks of additional treatment.
by Christina Szalinski
-
Breast Cancer: Making Treatment DecisionsWith additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski
-
Patients as Research PartnersNew platforms allow patients to share their clinical data and tumor tissue no matter where they live, offering everyone a chance to participate in research.
by Erin O'Donnell
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
-
Keeping Hope Alive—Why the Schlueters Rally for Medical ResearchRichard and Michelle Schlueter attended the Rally for Medical Research to advocate for NIH funding after budget cuts delayed his treatment.
-
Cancer in the Rearview Mirror: 15 Years of AACR Cancer Progress Report Survivor StoriesCancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
Cancer Research at a Crossroads
